CHU PHARMA and Shaanxi University of Science and Technology officially signed a long-term industry-university-research cooperation agreement. Leveraging the university's mature R&D capabilities in fine chemicals and pharmaceutical synthesis processes, they will jointly establish a pilot-scale and intermediate-scale API laboratory. The two parties will focus on iterative optimization of theobromine purification processes and plant extract refining technologies, achieving technological upgrades in three dimensions: reducing production costs, improving product purity and stability, and optimizing environmentally friendly production processes. This will create a closed-loop chain from "university R&D - factory mass production - foreign trade export."